Unibest
← Back to patent-cliff list

CAS 110-17-8

fumaric acidtrans-2-Butenedioic acid

Codes: LURA-007, VONO-011, Enalapril-006

Application context (from source-drug indications)

Major depressive disorderLurasidone HydrochlorideSchizophreniaLurasidone HydrochlorideManiaLurasidone HydrochlorideDepressive disorderLurasidone HydrochloridePeptic ulcer bleedingVonoprazan AcetateCardiac and vascular disordersAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHypertensionAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHyperlipidaemiaAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHeart diseaseAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHelicobacter pylori infectionVonoprazan FumarateOesophagitisVonoprazan FumarateGastro-oesophageal reflux diseaseVonoprazan FumarateHeartburnVonoprazan FumaratePeptic oesophagitisVonoprazan FumarateHelicobacter infectionVonoprazan FumarateEssential hypertensionEnalapril Maleate/Folic AcidHeart failureEnalapril MaleateHypertensionEnalapril MaleateMyocardial infarctionEnalapril MaleateAngina pectorisEnalapril MaleateLeft ventricular dysfunctionEnalapril MaleateSolid tumourEnalapril Maleate

Source drugs (routes using this intermediate)

DrugTierExpiry
Lurasidone HydrochlorideTier B — Position early2028
Vonoprazan AcetateTier C — Watch / trade2029
Atorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilTier C — Watch / trade-
Vonoprazan FumarateTier C — Watch / trade-
Enalapril Maleate/Folic AcidTier C — Watch / trade-
Dextran/Calcium Chloride/Potassium Chloride/Sodium Chloride/Sodium lactateTier C — Watch / trade-
Enalapril MaleateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site5-(2-fluorophenyl)-1H-pyrrole-3-carboxylic acid methyl ester
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Workspyridine-3-sulfonyl chloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site1H-Pyrrole-3-carboxylic acid, 5-(2-fluorophenyl)-, ethyl ester
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP SiteVonoprazan
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site3-Pyridinesulfonyl chloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.